Yes, you can give ketorolac (Toradol) injection to a patient already taking colchicine for acute gout pain.
NSAIDs like ketorolac are recommended first-line therapies for acute gout flares and can be used in patients already on colchicine, as these medications work through different mechanisms and are not contraindicated together. 1, 2
Clinical Reasoning
The 2020 ACR and 2017 ACP guidelines both strongly recommend NSAIDs (including ketorolac), colchicine, or corticosteroids as first-line options for treating acute gout flares 1, 2. These agents can be used interchangeably based on patient factors, and there is no guideline restriction against combining an NSAID with ongoing colchicine therapy.
Key Points About This Combination:
Different mechanisms of action: Colchicine works by inhibiting microtubule polymerization and reducing neutrophil migration, while NSAIDs like ketorolac inhibit prostaglandin synthesis. They target inflammation through distinct pathways.
No pharmacokinetic interaction: There is no documented drug-drug interaction between ketorolac and colchicine that would alter the metabolism or clearance of either medication 3.
Clinical evidence supports NSAIDs for acute gout: Ketorolac 60 mg IM has demonstrated rapid pain relief in acute gout, with mean pain scores dropping from 6.43 to 1.01 within 90 minutes 4.
Important Caveats and Safety Considerations:
When to Avoid NSAIDs (Use Alternative):
- Renal disease (CrCl < 30 mL/min or significant impairment)
- Heart failure (especially decompensated)
- Cirrhosis or severe liver disease
- Active peptic ulcer disease or history of GI bleeding
- Recent coronary artery bypass surgery 2
Colchicine-Specific Concerns:
While ketorolac itself doesn't interact with colchicine, be aware that colchicine toxicity risk increases with:
- Renal or hepatic impairment
- Concurrent use of strong CYP3A4 inhibitors (clarithromycin, ketoconazole)
- P-glycoprotein inhibitors 2, 3
Theoretical GI Risk:
One case report suggests that combining NSAIDs with colchicine may theoretically increase GI toxicity through additive effects on the gut wall 5. However, this is based on a single case in an elderly patient with multiple comorbidities and underlying diverticular disease. This should not prevent combination use in most patients, but exercise additional caution in elderly patients with known diverticular disease or significant GI comorbidities.
Practical Approach:
If the patient is already on colchicine for prophylaxis and develops an acute flare:
- Administer ketorolac 60 mg IM for rapid pain relief (if no contraindications to NSAIDs)
- Continue the prophylactic colchicine dose unchanged
- Do NOT give additional colchicine for flare treatment on top of the NSAID (this increases toxicity risk without added benefit)
If the patient took colchicine for acute flare treatment but needs additional pain control:
- Ketorolac can be added if the colchicine dose was appropriate (1.2 mg followed by 0.6 mg one hour later) 2
- This provides multimodal analgesia through different mechanisms
The guidelines do not prioritize one first-line agent over another, emphasizing that selection should be based on patient-specific contraindications and comorbidities 1, 2. In the absence of NSAID contraindications, ketorolac injection is a safe and effective option for acute gout pain in patients taking colchicine.